Press conference will discuss COVID-19 vaccine research, development, rollout in conjunction with the COVID-19 Vaccine Development, Strategy and Implementation Virtual Global Health Symposium, organized by Columbia University, running from 22-26 February
International experts are joining forces to combat vaccine hesitancy by tackling its root cause – misinformation – and arming key influencers with the facts.
Extending the symptoms that trigger a PCR test for COVID-19 could help detect around a third more cases of the disease.
The Johns Hopkins School of Nursing (JHSON) has launched a free online course to help individuals, health departments, and other community organizations be trained to administer COVID-19 vaccination. The course covers vaccine safety, hesitancy, preparation, administration, and side effects.
UC San Diego researchers report that individual immune response to SARS-CoV-2 may be limited by a set of variable genes that code for cell surface proteins essential for the adaptive immune system. The finding may help explain why COVID-19 immunity varies by individual.
A new Johns Hopkins data tool helps people with disabilities determine when they qualify for the COVID-19 vaccine and compares how different states prioritize the disability community in the vaccine rollout. Created by researchers, students and advocates who themselves are disabled and have personally experienced how inequitable and inaccessible the pandemic response has been, the COVID-19 Vaccine Prioritization Dashboard launched to not only help the disability community get vaccinated, but also to arm policymakers with data to improve the system.
A new analysis from the Geiger Gibson/RCHN Community Health Foundation Research Collaborative provides current information on the number of community health center staff members and patients who have received COVID-19 vaccines, using data from the latest published Health Resources and Services Administration’s Health Center COVID-19 Survey. The Geiger Gibson/RCHN Community Health Foundation Research Collaborative is based at the George Washington University Milken Institute School of Public Health (GW Milken Institute SPH).
For some people, anxiety over what may happen after they get the COVID-19 vaccine seems to almost outweigh the relief of getting protected. Here are some common questions and answers that should ease concerns.
130 cancer centers and other cancer organizations sent a letter to President Joseph R. Biden, key members of his administration, and leading state public health officials to strongly encourage prioritizing patients with cancer and survivors of cancer when administering lifesaving COVID-19 vaccines.
Researchers reporting in ACS’ Nano Letters have developed a hydrogel that, when injected into mice with melanoma, slowly released RNA nanovaccines that shrank tumors and kept them from metastasizing.
As part of the yearlong celebration of its 60th anniversary, the University of California San Diego will showcase the expertise of its award-winning faculty and acclaimed researchers with a virtual event series entitled Evenings of Nonconventional Wisdom.
Got a friend or family member who is eligible for the COVID-19 vaccine but not sure they want to get it? Here are a few strategies to get them to reconsider.
The webinar “Disseminating Facts, Dispelling Myths – Building COVID Vaccine Confidence in Communities” hosted by the American Journal of Nursing (AJN) explores why many Americans are hesitant to receive a COVID-19 vaccination and looks at the primary reasons for worry, including misinformation about side effects, lack of trust, and the rapid development of the vaccines.
Rich nations should not engage in “vaccine nationalism” and keep the COVID-19 vaccine to themselves when poorer nations need them, according to Nicole Hassoun, professor of philosophy at Binghamton University, State University of New York.
The Mount Sinai Health System is joining medical centers across the United States in a grassroots effort to encourage public participation in vaccinations against COVID-19.
Headlines going viral on Facebook and elsewhere on social media are spreading the claim that the COVID-19 vaccine could lead to infertility in women. There is currently no data to support this claim. Experts weigh in...
Supporting its mission of public service, the CSU is hosting COVID vaccination clinics statewide to help end the pandemic.
By capitalizing on a convergence of chemical, biological and artificial intelligence advances, scientists have developed an unusually fast and efficient method for discovering tiny antibody fragments with big potential for development into therapeutics against deadly diseases.
The American College of Rheumatology (ACR) has released its COVID-19 Vaccine Clinical Guidance Summary that provides an official recommendation to vaccinate rheumatology patients with musculoskeletal, inflammatory and autoimmune diseases. Important considerations and caveats on how to approach vaccination are included for patients with high disease activity and/or those taking immunosuppressant treatments.
Research from the University of Kent, Goethe-University in Frankfurt am Main, and the Philipps-University in Marburg has provided crucial insights into the biological composition of SARS-CoV-2, the cause of COVID-19, revealing vital clues for the discovery of antiviral drugs.
Launched in 1988, the Global Polio Eradication Initiative (GPEI) stands out as one of the largest, internationally coordinated global public health major projects conducted to date, with cumulative spending of over $16.5 billion for 1988–2018, according to the World Health Organization (WHO). More than 30 years later, stubborn outbreaks of wild poliovirus still occur in Afghanistan and Pakistan, where cases have been increasing since 2018. The global eradication of polio continues to be an elusive goal.
Justin Brandt, an assistant professor in the Division of Maternal Fetal Medicine at Rutgers Robert Wood Johnson Medical School and director of quality and safety for the department of OB/GYN, talks about the information provided by the Centers for Disease Control and Prevention and what pregnant women should consider when deciding whether to get the COVID-19 vaccine.
Scientific and public health experts have been raising the alarm for decades, imploring public officials to prepare for the inevitability of a viral pandemic.
A new interactive dashboard from UAB and PathCheck Foundation will enable users to see the quantity and location of vaccines distributed across the country and world in real time.
In the age of COVID-19, decisions that affect our day-to-day lives are influenced by analyzing numbers and data. For example, the COVID-19 positivity rate (the percentage of people who test positive for the virus out of the total number tested) influence whether or not businesses may open to the public, or, if schools should offer virtual, hybrid or in-class learning. Data are critical for strategizing, planning and implementing the policies and procedures needed to respond to the crisis and keep people safe.
A new Annals of Internal Medicine editorial co-authored by a University of Chicago Medicine health disparities researcher offers practical tips for clinicians to discuss the COVID-19 vaccine with patients of color who may be hesitant to get vaccinated.
Rutgers medical faculty who have received their second COVID-19 vaccination discuss their side effects and give advice for those still to be vaccinated
A vaccine for use against the deadly Nipah and Hendra viruses has demonstrated effectiveness in preclinical studies as early as 7 days following a single immunization, according to a new study, "A Single Dose Investigational Subunit Vaccine for Human Use against Nipah virus and Hendra virus," published in the journal, npj Vaccines, online February 8, 2021.
DALLAS – Feb. 8, 2021 – Pregnant women, who are at increased risk of preterm birth or pregnancy loss if they develop a severe case of COVID-19, need the best possible guidance on whether they should receive a COVID-19 vaccine, according to an article by two UT Southwestern obstetricians published today in JAMA. That guidance can take lessons from what is already known about other vaccines given during pregnancy.
A new national survey of more than 2,000 Americans by The Ohio State University Wexner Medical Center finds most plan to continue many of the pandemic precautions in the name of public health, even when the pandemic is over.
Experts will discuss and take questions on COVID-19 vaccine distribution.
Rutgers was the second-largest Phase 3 clinical research trial site for Johnson & Johnson’s COVID-19 vaccine, which applied for emergency use authorization today from the U.S. Food and Drug Administration.
New research carried out by City data scientist, Dr Andrea Baronchelli, and colleagues, into the dark web marketplace (DWM) trade in products related to COVID-19, has revealed the need for the continuous monitoring of dark web marketplaces (DWMs), especially in light of the current shortage and availability of coronavirus vaccines.
Researchers from the University of Missouri School of Medicine have discovered that children who receive a seasonal flu shot are less likely to suffer symptoms from a COVID-19 infection.
SEATTLE —Feb. 4, 2021 —Below are summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.We are looking forward to the Transplantation & Cellular Therapy Meetings, to be held online Feb. 8-12. Read highlights of Fred Hutch research to be presented, including on COVID-19 and cancer and new insights on treating graft-vs.
It is necessary to develop additional COVID-19 vaccines, as different vaccine approaches have their advantages and disadvantages and may work synergistically.
The Tuskegee syphilis experiment. The secret sale of Henrietta Lacks cancer research cells. Jim Crow laws affecting African Americans' ability to receive medical treatment. For weeks, it’s been hard to hear over the clamor of millions of Americans lining up for COVID-19 vaccines. But not everyone has been enthused — namely, large swaths of minority communities, which comprise the populations disproportionately impacted by the virus, but whose hesitance is largely fueled by the country’s racist medical past.
The 2019-2020 flu season in the U.S. was unusual in a number of ways. Cases picked up in August rather than the more typical fall and early winter months, and it hit children particularly hard.
Smartphones have helped many people endure the pandemic. But apps and text-message systems can also help fight COVID-19, by alerting smartphone users about their exposures, helping them make a vaccination appointment and track vaccine reaction, and more.
Similar to the idea of "food deserts," many urban Black neighborhoods lack pharmacies, clinics, hospitals or health centers that can administer COVID-19 vaccines. The analysis, including a detailed facility map, points to the places where there is a need for temporary mass vaccination sites.
Unpacking biomedicine, traditional knowledges and healing practices though oral storytelling and visualizations to support First Nations, Inuit and Métis in making informed choices.
The ACEN and OADN strongly encourage nursing programs to actively identify how they can support vaccine delivery in their communities. For full engagement in the vaccine effort, our organizations urge nursing students and faculty to receive the COVID-19 vaccine as soon as it is available to them.
Researchers from Cornell and Northwestern University have devised a new method of using extracts derived from bioengineered bacteria to create vaccines that protect against life-threatening infections caused by pathogenic bacteria.
The AANEM Quality & Patient Safety Committee has published the paper, “Doctor – Should I get the COVID-19 vaccine? Infection and Immunization in Individuals with Neuromuscular Disorders."
A scientific detective story starting with a single patient in Pittsburgh unearths how the SARS-CoV-2 virus mutates to create new variants, including the UK strain B.1.1.7, and escapes neutralizing antibodies.
The United States will begin participating in an international collaboration to distribute COVID-19 vaccines more equitably around the world after President Joe Biden reversed the Trump administration’s withdrawal from the World Health Organization on his first day in office. Richard Marlink, the director of Rutgers Global Health Institute, discusses the impact COVAX, the global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines, will have on ending the COVID-19 pandemic and strengthening global health.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right